Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer
CA 2331295 A1 · Owner: Newton, Roger Schofield · Inventors: Leopold, Judith; Newton, Roger Schofield
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel combinations of inhibitors of protein farnesyltransferase enzymes and HMG CoA reductases enzymes are described as well as methods for the , preparation and pharmaceutical compositions of the same which are useful in , preventing or treating cancer restenosis, psoriasis, endometriosis, atherosclerosis or viral infections.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 10, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 10, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 10, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.